The Filing Desk

Maravai LifeSciences vs Personalis

Maravai LifeSciences MRVI · Personalis PSNL · Life Sciences Tools & Services

Maravai LifeSciences reported revenue of $186 million in fiscal 2025, 2.7 times Personalis' $70 million in fiscal 2025. Maravai LifeSciences' revenue fell 28.3% in its latest year, and Personalis' fell 17.7%. Maravai LifeSciences had an operating margin of -115.9%, against -126.4% at Personalis. Free cash flow was −$71 million at Maravai LifeSciences and −$79 million at Personalis.

Side by side

Maravai LifeSciencesPersonalis
Latest fiscal yearFY2025, Dec 31, 2025FY2025, Dec 31, 2025
Revenue$186M$70M
Revenue growth−28.3%−17.7%
Revenue growth a year, last 5 years−8.2%−2.4%
Gross margin18.3%22.6%
Operating margin−115.9%−126.4%
Net margin−70.4%−116.7%
Free cash flow−$71M−$79M
Free cash flow margin−38.1%−114.1%
Return on capital−32.0%—
Net debt to EBITDA——
Dividends and buybacks$0M$0M
Change in diluted share count4.7%50.6%
Last close$7.54$15.71
P/E at the last close——
Insider trades, last 12 months——
Piotroski F-score2 of 9—
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.

Ten years

Revenue
US$ billions, fiscal years
Maravai LifeSciencesPersonalis
Operating margin
Percent of revenue
Maravai LifeSciencesPersonalis
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
Maravai LifeSciencesPersonalis

Start a new comparison

Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Maravai LifeSciences and Personalis pages.